企业版公测上线啦!点击立即查看
登录 注册
当前位置: 首页 > FDA历年批准NMEs及Biologics 反馈纠错 帮助中心
药智数据企业版注册数据库:增设了"联合申报"、"临床试验默认许可日期"等搜索条件,让搜索页面纬度更加全面,还有热点搜索和高级条件组合检索等检索功能 等你来体验!
-
批准类型 药品名称 活性成分 适应症 上市发布公告 临床试验快照 批准日期 申请机构
NME Xpovio selinexor To treat adult patients with relapsed or refractory multiple myeloma (RRMM) Press Release 2019/07/03 KARYOPHARM THERAPEUTICS INC
Biologics Polivy polatuzumab vedotin-piiq To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma Press Release 2019/06/10 GENENTECH
NME Piqray alpelisib To treat breast cancer Press Release Drug Trials Snapshot 2019/05/24 NOVARTIS PHARMS CORP
NME Vyndaqel tafamidis meglumine To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults Press Release  Drug Trials Snapshot 2019/05/03 FOLDRX PHARMS
Biologics Skyrizi risankizumab-rzaa To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy Drug Trials Snapshot 2019/04/23 ABBVIE INC
NME Balversa erdafitinib To treat adult patients with locally advanced or metastatic bladder cancer Press Release Drug Trials Snapshot 2019/04/12 JANSSEN BIOTECH
Biologics Evenity romosozumab-aqqg To treat osteoporosis in postmenopausal women at high risk of fracture Press Release Drug Trials Snapshot 2019/04/09  AMGEN INC
NME Mayzent siponimod To treat adults with relapsing forms of multiple sclerosis Press Release Drug Trials Snapshot 2019/03/26  NOVARTIS PHARMS CORP
NME Sunosi solriamfetol To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea Drug Trials Snapshot 2019/03/20  JAZZ
NME Zulresso brexanolone To treat postpartum depression (PPD) in adult women Press Release Drug Trials Snapshot 2019/03/19 SAGE THERAP
NME Egaten triclabendazole To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” Drug Trials Snapshot 2019/02/13 NOVARTIS PHARMS CORP
Biologics Cablivi caplacizumab-yhdp To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) Press Release Drug Trials Snapshot 2019/02/06 ABLYNX NV
Biologics JEUVEAU PRABOTULINUMTOXINA-XVFS For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients Drug Trials Snapshot 2019/02/01 EVOLUS INC
Biologics Elzonris tagraxofusp-erzs To treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) Press Release Drug Trials Snapshot 2018/12/21 STEMLINE THERAPEEUTICS INC
Biologics Ultomiris ravulizumab To treat paroxysmal nocturnal hemoglobinuria (PNH) Press Release Drug Trials Snapshot 2018/12/21 ALEXION PHARM
Biologics Asparlas calaspargase pegol-mknl To treat acute lymphoblastic leukemia (ALL) in pediatric and young adult patients age 1 month to 21 years Drug Trials Snapshot 2018/12/20 SERVIER PHARMA LLC
NME Motegrity prucalopride To treat chronic idiopathic constipation Drug Trials Snapshot 2018/12/14 SHIRE DEV LLC
NME Firdapse amifampridine To treat Lambert-Eaton myasthenic syndrome (LEMS) in adults Press Release 2018/11/28 CATALYST PHARMA INC
NME Xospata gilteritinib To treat patients who have relapsed or refractory acute myeloid leukemia (AML) Press Release 2018/11/28 ASTELLAS
NME Vitrakvi larotrectinib To treat patients whose cancers have a specific genetic feature (biomarker) Press Release 2018/11/26 LOXO ONCOLOGY INC